Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants

Abstract

The radiosensitizing effect of caffeine has been associated with the disruption of multiple DNA damage-responsive cell cycle checkpoints, but several lines of evidence also implicate inhibition of DNA repair. The role of DNA repair inhibition in caffeine radiosensitization remains uncharacterized, and it is unknown which repair process, or lesion, is affected. We show that a radiosensitive cell line, mutant for the RAD51 homolog XRCC2 and defective in homologous recombination repair (HRR), displays significantly diminished caffeine radiosensitization that can be restored by expression of XRCC2. Despite the reduced radiosensitization, caffeine effectively abrogates checkpoints in S and G2 phases in XRCC2 mutant cells indicating that checkpoint abrogation is not sufficient for radiosensitization. Another radiosensitive line, mutant for XRCC3 and defective in HRR, similarly shows reduced caffeine radiosensitization. On the other hand, a radiosensitive mutant (irs-20) of DNA-PKcs with a defect in non-homologous endjoining (NHEJ) is radiosensitized by caffeine to an extent comparable to wild-type cells. In addition, rejoining of radiation-induced DNA DSBs, that mainly reflects NHEJ, remains unaffected by caffeine in XRCC2 and XRCC3 mutants, or their wild-type counterparts. These observations suggest that caffeine targets steps in HRR but not in NHEJ and that abrogation of checkpoint response is not sufficient to explain radiosensitization. Indeed, immortalized fibroblasts from AT patients show caffeine radiosensitization despite the checkpoint defects associated with ATM mutation. We propose that caffeine radiosensitization is mediated by inhibition of stages in DNA DSB repair requiring HRR and that checkpoint disruption contributes by allowing these DSBs to transit into irreparable states. Thus, checkpoints may contribute to genomic stability by promoting error-free HRR.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bates PR, Imray FP and Lavin MF. . 1985 Int. J. Radiat. Biol. 47: 713–722.

  • Bebb DW, Steele PP, Warrington PJ, Moffat JA and Glickman BW. . 1998 Mutation Res. 401: 27–32.

  • Beetham KL and Tolmach LJ. . 1982 Radiat. Res. 91: 199–211.

  • Beetham KL and Tolmach LJ. . 1984 Radiat. Res. 100: 104–114.

  • Beetham KL and Tolmach LJ. . 1986 Radiat. Res. 107: 272–285.

  • Bernhard EJ, Muschel RJ, Bakanauskas VJ and McKenna WG. . 1996 Int. J. Radiat. Biol. 69: 575–584.

  • Blasina A, Price BD, Turenne GA and McGowan CH. . 1999 Curr. Biol. 9: 1135–1138.

  • Busse PM, Bose SK, Jones RW and Tolmach LJ. . 1977 Radiat. Res. 71: 666–677.

  • Busse PM, Bose SK, Jones RW and Tolmach LJ. . 1978 Radiat. Res. 76: 292–307.

  • Carr AM. . 1995 Sem. Cell Biol. 6: 65–72.

  • Cartwright R, Tambini CE, Simpson PJ and Thacker J. . 1998 Nucl. Acids Res. 1998: 3084–3089.

  • Cheong N, Wang X, Wang Y and Iliakis G. . 1994 Mutation Res. 314: 77–85.

  • Cheong N, Wang Y, Jackson M and Iliakis G. . 1992 Mutation Res. 274: 111–122.

  • DiBiase SJ, Zeng Z-C, Chen R, Hyslop T, Curran Jr WJ and Iliakis G. . 2000 Cancer Res. 60: 1245–1253.

  • Domon M and Rauth AM. . 1969 Radiat. Res. 39: 207–221.

  • Fabre F. . 1972 Mol. Gen. Gen. 117: 153–166.

  • Fan S, Smith ML, Rivet DJ, Duba D, Zhang Q, Kohn KW, Fornace Jr AJ and O'Connor PM. . 1995 Cancer Res. 55: 1649–1654.

  • Frankenberg-Schwager M. . 1989 Radiother Oncology 14: 307–320.

  • Fuller LF and Painter RB. . 1988 Mutation Res. 193: 109–121.

  • Furcinitti PS. . 1993 Radiat. Res. 95: 197–204.

  • Garattini S. (ed.) . 1993 Caffeine, Coffee, and Health. Raven Press, Ltd., New York pp. 1–405.

  • Gentner NE. . 1981 Mol. Gen. Gen. 181: 283–287.

  • Gentner NE, Werner MM, Hannan MA and Nasim A. . 1978 Mol. Gen. Gen. 167: 43–49.

  • Griffiths TD, Carpenter JG and Dahle DB. . 1978 Int. J. Radiat. Biol. 33: 493–505.

  • Guan J, DiBiase S and Iliakis G. . 2000 Nuc. Acids Res. 28: 1183–1192.

  • Hall-Jackson CA, Cross DAE, Morrice N and Smythe C. . 1999 Oncogene 18: 6707–6713.

  • Hansson K, Natarajan AT and Kihlman BA. . 1984 Human Genetics 67: 329–335.

  • Hartwell LH and Kastan MB. . 1994 Science 266: 1821–1828.

  • Hartwell LH and Weinert TA. . 1989 Science 246: 629–634.

  • Harvey AN and Savage JRK. . 1994 Mutation Res. 304: 203–209.

  • Iliakis G. . 1988 Int. J. Radiat. Biol. 53: 541–584.

  • Iliakis G. . 1991 BioEssays 13: 641–648.

  • Iliakis G, Metzger L, Denko N and Stamato TD. . 1991a Int. J. Radiat. Biol. 59: 321–341.

  • Iliakis G and Nusse M. . 1983a Int. J. Radiat. Biol. 43: 649–663.

  • Iliakis G and Nusse M. . 1983b Radiat. Res. 95: 87–107.

  • Iliakis G, Cicilioni O and Metzger L. . 1991b Int. J. Radiat. Biol. 59: 343–357.

  • Jeggo PA. . 1998 Advances in Genetics 38: 186–218.

  • Johnson RD, Liu N and Jasin M. . 1999 Nature 401: 397–399.

  • Jones NJ, Cox R and Thacker J. . 1987 Mutation Res. 183: 279–286.

  • Jones NJ, Stewart SA and Thompson LH. . 1990 Mutagenesis 5: 15–23.

  • Jung T and Streffer C. . 1992 Int. J. Radiat. Biol. 62: 161–168.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1991 Cancer Res. 51: 6304–6311.

  • Kihlman BA. . (1977). Elsevier Scientific Publishing Co.: Amsterdam, New York, Oxford pp 1–504.

  • Kimler BF, Leeper DB, Snyder MH, Rowley R and Schneiderman MH. . 1982 Int. J. Radiat. Biol. 41: 47–58.

  • Lau CC and Pardee AB. . 1982 Proc. Natl. Acad. Sci. USA 79: 2942–2946.

  • Lehmann AR. . 1972 Biophys. J. 12: 1316–1325.

  • Lehmann AR. . 1996 Mutation Res. 363: 147–161.

  • Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR, Brookman KW, Siciliano MJ, Walter CA, Fan W, Narayana LS, Zhou Z-Q, Adamson AW, Sorensen KJ, Chen DJ, Jones NJ and Thompson LH. . 1998 Mol. Cell 1: 783–793.

  • Loprieno N, Barale R and Baroncelli S. . 1973 Mutation Res. 21: 275.

  • Loprieno N, Barale R and Baroncelli S. . 1974 Mutation Res. 26: 83–87.

  • Loprieno N and Schupbach M. . 1971 Mol. Gen. Gen. 110: 348–354.

  • Lucke-Huhle C. . 1982 Radiat. Res. 89: 298–308.

  • Morrison C, Sonoda E, Takao N, Shinohara A, Yamato K-i and Takeda S. . 2000 EMBO J. 19: 463–471.

  • Moser BA, Brondello J-M, Barber-Furnari B and Russell PS. . 2000 Mol. Cell. Biol. 20: 4288–4294.

  • Murnane JP. . 1995 Cancer and Metastasis Reviews 14: 17–29.

  • Murnane JP, Byfield JE, Ward JF and Calabro-Jones P. . 1980 Nature 285: 326–329.

  • Musk SRR. . 1991 Radiat. Res. 125: 262–266.

  • Musk SRR and Steel GG. . 1990 Int. Radiat. Biol. 57: 1105–1112.

  • Nasim A and Smith BP. . 1974 Mol. Gen. Gen. 132: 13–22.

  • Natarajan AT, Obe G and Dulout FN. . 1980 Human Genetics 54: 183–189.

  • Nevaldine B, Longo JA and Hahn PJ. . 1997 Radiat. Res. 147: 535–540.

  • Osman F and McCready S. . 1998 Mol. Gen. Gen. 260: 319–334.

  • Painter RB. . 1980 J. Mol. Biol. 143: 289–301.

  • Palayoor ST, Macklis RM, Bump EA and Coleman CN. . 1995 Radiat. Res. 141: 235–243.

  • Pawlak AL, Kotecki M and Ignatowicz R. . 1990 Mutation Res. 230: 197–204.

  • Pierce AJ, Johnson RD, Thompson LH and Jasin M. . 1999 Genes Dev. 13: 2633–2638.

  • Powell SN, DeFrank J, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W and Friend S. . 1995 Cancer Res. 55: 1643–1648.

  • Priestley A, Beamish JH, Gell D, Amatucci AG, Muhlmann-Diaz MC, Singleton SP, Smith GCM, Blunt T, Schalkwyk LC, Bedford JS, Jeggo PA and Taccioli GE. . 1998 Nucl. Acids Res. 26: 1965–1973.

  • Ribeiro JCC, Barnetson AR, Jackson P, Ow K, Links M and Russell PJ. . 1999 Int. J. Radiat. Biol. 75: 481–492.

  • Rowley R. . 1992 Radiat. Res. 129: 224–227.

  • Rowley R and Zhang J. . 1999 Genetics 152: 61–71.

  • Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE and Groudine M. . 1995 Cancer Res. 55: 1639–1642.

  • Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT. . 1999 Cancer Res. 59: 4375–4382.

  • Schlegel R and Pardee AB. . 1986 Science 232: 1264–1266.

  • Shinomiya N, Takemura T, Iwamoto K and Rokutanada M. . 1997 Cytometry 27: 365–373.

  • Siede W, Obermaier S and Eckardt F. . 1985 Radiat. Environ. Biophys. 24: 1–7.

  • Smith GCM and Jackson SP. . 1999 Genes Dev. 13: 916–934.

  • Stackhouse MA and Bedford JS. . 1993a Radiat. Res. 136: 241–249.

  • Stackhouse MA and Bedford JS. . 1993b Radiat. Res. 136: 250–254.

  • Stackhouse MA and Bedford JS . 1994 Int. J. Radiat. Biol. 65: 571–582.

  • Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A and Takeda S. . 1998 EMBO J. 17: 5497–5508.

  • Tambini CE, George AM, Rommens JM, Tsui L-C, Scherer SW and Thacker J. . 1997 Genomics 41: 84–92.

  • Tatsumi K and Strauss BS. . 1979 J. Mol. Biol. 135: 435–449.

  • Taylor YC, Parsian AJ and Duncan PG. . 1993 Int. J. Radiat. Biol. 64: 57–70.

  • Thacker J. . 1999 Trends in Genetics 15: 166–168.

  • Thacker J and Ganesh AN. . 1990 Mutation Res. 235: 49–58.

  • Thompson LH and Schild D. . 1999 Biochimie 81: 87–105.

  • Timson J. . 1977 Mutation Res. 47: 1–52.

  • Tolmach LJ and Busse PM. . 1980 Radiat. Res. 82: 374–392.

  • Tolmach LJ, Jones RW and Busse PM. . 1977 Radiat. Res. 71: 653–665.

  • Tomasovic SP and Dewey WC. . 1978 Radiat. Res. 74: 112–128.

  • Ts'o PO and Lu P. . 1964 Proc. Natl. Acad. Sci. USA 51: 17–28.

  • Valenzuela MT, Mateos S, de Almodovar JMR and McMillan TJ. . 2000 Radiother Oncology 54: 261–271.

  • Waldren CA and Rasko I. . 1978 Radiat. Res. 73: 95–110.

  • Walters RA, Gurley LR and Tobey RA. . 1974 Biophys. J. 14: 99–118.

  • Wang H, Zeng Z-C, Bui T-A, Sonoda E, Takata M, Takeda S and Iliakis G. . 2000 Submitted.

  • Wang S-W, Norbury C, Harris AL and Toda T. . 1999 J. Cell Sci. 112: 927–937.

  • Ward JF. . 1985 Radiat. Res. 104: S103–S111.

  • Yao S-L, Akhtar AJ, McKenna KA, Bedi GC, Sidransky D, Mabry M, Ravi R, Collector MI, Jones RJ, Sharkis SJ, Fuchs EJ and Bedi A. . 1996 Nature Medicine 2: 1140–1143.

  • Zampetti-Bosseler F and Scott D. . 1985 Mutation Res. 143: 251–256.

  • Zhou B-BS, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, Mattern MR, Winkler JD and Khanna KK. . 2000 J. Biol. Chem. 275: 10342–10348.

Download references

Acknowledgements

Supported by NCI Grant 2RO1 CA42026, 56706 and P30-CA56036 awarded from NIH, DHHS and by NASA's Biomedical Research and Countermeasures Program and the Advanced Human Support Technology Program under NRA's 96-HEDS-04 and 96-HEDS-05. The authors are indebted to Drs Colin Arlett, Joel Bedford and Larry Thompson for cells. Special thanks go to Ms Nancy Mott for help in the preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Asaad, N., Zeng, ZC., Guan, J. et al. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants. Oncogene 19, 5788–5800 (2000). https://doi.org/10.1038/sj.onc.1203953

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203953

Keywords

Search

Quick links